CRIS Current Research Information System

NANNINI, MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.469
EU - Europa 4.662
AS - Asia 2.436
AF - Africa 383
SA - Sud America 23
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.428
GB - Regno Unito 1.078
IT - Italia 1.073
CN - Cina 924
SG - Singapore 622
SE - Svezia 588
DE - Germania 534
VN - Vietnam 422
IN - India 273
IE - Irlanda 237
CH - Svizzera 234
RU - Federazione Russa 189
FR - Francia 174
UA - Ucraina 163
TG - Togo 145
ZA - Sudafrica 96
EE - Estonia 93
CI - Costa d'Avorio 88
FI - Finlandia 74
JO - Giordania 44
BG - Bulgaria 43
AT - Austria 41
NG - Nigeria 39
CA - Canada 36
ID - Indonesia 34
BE - Belgio 30
PL - Polonia 23
NL - Olanda 21
IR - Iran 20
JP - Giappone 18
AU - Australia 13
GR - Grecia 13
PK - Pakistan 13
MY - Malesia 12
HK - Hong Kong 11
BR - Brasile 10
HR - Croazia 10
CL - Cile 8
TR - Turchia 8
ES - Italia 7
SC - Seychelles 7
CZ - Repubblica Ceca 6
LB - Libano 6
SK - Slovacchia (Repubblica Slovacca) 6
MU - Mauritius 5
DK - Danimarca 4
KR - Corea 4
NI - Nicaragua 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
TW - Taiwan 4
LT - Lituania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
YE - Yemen 1
Totale 14.989
Salva come PNG Salva come JPEG
Città #
Southend 996
Fairfield 903
Chandler 740
Ashburn 610
Singapore 555
Woodbridge 441
Wilmington 412
Houston 384
Seattle 365
Santa Clara 346
Bologna 334
Cambridge 303
Princeton 287
Ann Arbor 269
Dublin 237
Bern 219
Dong Ket 195
Boardman 175
Lomé 145
Redmond 142
Nanjing 113
Westminster 111
Berlin 95
Padova 90
Abidjan 88
New York 86
Jacksonville 82
Beijing 66
Helsinki 64
Jinan 60
Turin 59
Milan 57
San Diego 50
Shenyang 48
Amman 44
Saint Petersburg 43
Sofia 43
Los Angeles 41
Abeokuta 38
Nanchang 37
Falls Church 36
Jakarta 34
Vienna 33
Bremen 32
Hyderabad 32
Changsha 31
Jiaxing 31
Brussels 30
Hebei 30
Rome 30
Des Moines 29
Zhengzhou 29
Dearborn 26
Toronto 26
Medford 25
Kuban 24
Shanghai 24
Guangzhou 23
Mülheim 23
Florence 22
Hangzhou 22
Tianjin 22
Olalla 21
Fremont 18
London 18
Norwalk 18
Redwood City 18
Bühl 17
Taizhou 17
Warsaw 17
Modena 15
San Francisco 15
Cesena 14
Ningbo 14
Phoenix 14
Ravenna 14
Hefei 13
Potenza 13
Taiyuan 13
Fuzhou 12
Lanzhou 12
Lugo 12
Haikou 11
Lappeenranta 10
Moscow 10
Mountain View 10
Paris 10
Wuhan 10
Zanjan 10
Amsterdam 9
Kuala Lumpur 9
Kunming 9
São Paulo 9
Chongqing 8
Falkenstein 8
Monmouth Junction 8
Naples 8
San Venanzo 8
Shenzhen 8
Tokyo 8
Totale 10.455
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 276
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 211
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 194
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 180
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 179
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 176
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 173
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 162
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 162
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 162
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 161
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 153
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 151
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 150
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 150
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 145
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 145
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 143
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 143
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 142
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 142
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 141
Characterization of malignant gastrointestinal stromal tumors-a single center experience. 140
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 139
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 139
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 135
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 135
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 135
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 135
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 133
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 133
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 133
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 132
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 132
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 131
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 129
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 127
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 127
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 127
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 127
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 126
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 125
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression 124
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 124
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 123
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 121
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 121
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. 120
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 119
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 118
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 118
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 118
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 118
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 116
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 116
SDHC methylation in gastrointestinal stromal tumors (GIST): a case report 114
Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST). 114
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 114
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST). 113
Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense? (Review) 109
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis 109
Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs). 109
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 107
Identification of oncogenic events in gastrointestinal stromal tumors (GISTs) by combined gene expression and copy number analysis. 107
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 107
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 106
Radiotherapy in the management of gist: state of the art and new potential scenarios 106
Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients 105
Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report 105
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 104
Quadruplewild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways 103
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 102
The follow-up after radical surgery of colorectal cancer: is it time for a "tailored" strategy? 101
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 101
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 101
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study 101
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 100
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 99
null 98
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future. Review 97
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 96
Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GIST 96
miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers 95
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy 94
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 94
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 94
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 93
The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting 92
Prognostic Evaluation of Localized Primary Gastrointestinal Stromal Tumors (GIST): Comparison between Risk Classification Systems and Role of Mutational Analysis in a Single Unit Experience 91
Genetic aberrations and molecular biology of cardiac sarcoma 91
Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis 91
The follow-up issues: from the necessity to the opportunity 90
null 90
Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis 90
Gene expression profiling differences between synchronous and metachronous metastases of colorectal cancer. 88
The Response Evaluation Criteria in Solid Tumors: until when? 88
Unusual finding of benign Abrikossoff tumor by F-18 FDG-PET mimicking melanoma recurrence. 87
null 87
Gene expression profiling of liver metastases from colorectal cancer: differencens between synchronous and metachronous lesions 87
Current status of the adjuvant therapy in uterine sarcoma: A literature review 87
Totale 12.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.288 0 0 0 0 0 339 442 442 454 243 174 194
2020/20211.860 397 122 93 65 28 97 25 100 269 107 105 452
2021/20222.670 282 101 110 183 233 119 63 231 125 169 592 462
2022/20233.411 365 495 178 400 190 231 98 203 542 109 267 333
2023/20241.140 124 165 57 131 98 183 63 85 35 61 62 76
2024/20252.029 197 487 338 294 552 161 0 0 0 0 0 0
Totale 15.449